Position in PFE
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$579,918
-$182,341 QoQ
Shares Held
24,083
-11.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,651
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026D'Orazio & Associates, Inc. holds $10,937,903 across 10 Drug Manufacturers - General names. PFE ranks #7 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,747 | $2,475,445 | |
| 2 | LLY |
ELI LILLY & Co
|
2,049 | $2,457,632 | |
| 3 | ABBV |
AbbVie Inc.
|
5,514 | $1,387,542 | |
| 4 | AMGN |
Amgen Inc
|
3,096 | $1,121,123 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
7,176 | $906,615 | |
| 6 | NVS |
Novartis AG
|
4,370 | $684,866 | |
| 7 | PFE |
Pfizer Inc
This page
|
24,083 | $579,918 | |
| 8 | MRK |
Merck & Co., Inc.
|
4,050 | $520,425 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $579,918 | 24,083 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $762,259 | 27,146 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $660,099 | 26,510 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $353,866 | 13,888 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $239,733 | 9,890 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $223,752 | 8,830 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $200,274 | 7,549 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $207,152 | 7,158 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $211,165 | 7,547 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $211,760 | 7,631 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $226,663 | 7,873 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $283,139 | 8,536 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $365,039 | 9,952 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $256,999 | 6,299 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $432,055 | 8,432 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $468,232 | 10,700 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $483,457 | 9,221 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $423,426 | 8,179 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $455,511 | 7,714 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $291,392 | 6,775 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $244,084 | 6,233 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $199,808 | 5,515 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $212,172 | 5,764 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $214,841 | 5,854 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $186,128 | 5,692 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $185,264 | 5,676 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||